A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

May 20, 2020

Study Completion Date

October 1, 2020

Conditions

Healthy Male Participants

Interventions

DRUG

E3112

Intravenous infusion.

OTHER

Placebo

Intravenous infusion.

Trial Locations (1)

EA Pharma Trial Site, Higashi

All Listed Sponsors

lead

EA Pharma Co., Ltd.

INDUSTRY

NCT03922633 - A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter